Net profit of Venmax Drugs & Pharmaceuticals reported to Rs 0.02 crore in the quarter ended September 2025 as against net loss of Rs 0.30 crore during the previous quarter ended September 2024. Sales rose 676.47% to Rs 1.32 crore in the quarter ended September 2025 as against Rs 0.17 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1.320.17 676 OPM %3.03-176.47 - PBDT0.04-0.30 LP PBT0.04-0.30 LP NP0.02-0.30 LP Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals announced that the 36th Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 September 2025.Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 August 2025.Powered by Capital Market - Live News